Get the Stockscreener App
0.2218
3.57%
-0.0082
Sunshine Biopharma Inc Stock (SBFM) Forecast
The Sunshine Biopharma Inc (SBFM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $34,361.91, representing a +15.49M% increase from the current price of $0.2218. The highest analyst price target is $65,775.67, and the lowest is $2,948.15.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SBFM Price Target
Average 82,084.20
(+37.01M% Upside)
Is Sunshine Biopharma Inc (SBFM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 26.46 | Buy |
| STOCH(9,6) | 1.8014 | Buy |
| STOCHRSI(14) | 44.53 | Neutral |
| MACD(12,26) | -0.2177 | Sell |
| ADX(14) | 27.23 | Buy |
| William %R | -97.36 | Buy |
| CCI(14) | -65.60 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.3519
Sell
|
0.3639
Sell
|
| MA20 |
0.5793
Sell
|
0.5342
Sell
|
| MA50 |
0.9093
Sell
|
1.0073
Sell
|
| MA100 |
1.4759
Sell
|
2.3705
Sell
|
| MA200 |
6.0933
Sell
|
5.3895
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SBFM could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on SBFM, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 26.46 indicates that SBFM is oversold. This indicates that SBFM price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 1.8014 indicates that SBFM is oversold. This indicates that SBFM price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 44.53 indicates that SBFM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.23 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -65.6 indicates that SBFM is still oversold but not to an extreme extent.
Long-term SBFM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Sunshine Biopharma Inc financial reports and earnings history, Sunshine Biopharma Inc (SBFM) stock could reach $13,429.99 by 2030, $51,240.23 by 2040 and $97,350.70 by 2050. See the projected annual prices until 2050 of the Sunshine Biopharma Inc stock below:
- Sunshine Biopharma Inc (SBFM) is expected to reach an average price of $29,663.05 in 2035, with a high prediction of $30,664.69 and a low estimate of $29,664.65. This indicates an $13.37M% rise from the last recorded price of $0.2218.
- Sunshine Biopharma Inc (SBFM) stock is projected to chart a bullish course in 2040, with an average price target of $49,763.99, representing an $22.44M% surge from its current level. The forecast ranges from a conservative $49,767.19 to a sky-high $51,240.23.
- Our analysts predict Sunshine Biopharma Inc (SBFM) to jump 33.04M% by 2045, soaring from $73,084.30 to an average price of $73,287.76, potentially reaching $74,230.83. While $73,084.30 is the low estimate, the potential upside is significant.
- Sunshine Biopharma Inc (SBFM) stock is expected to climb by 2050, reaching an average of $95,534.36, a $43.07M% jump from its current level. However, a wide range of estimates exists, with high and low targets of $97,350.70 and $96,052.36, respectively, highlighting the market's uncertainty.
Sunshine Biopharma Inc Stock (SBFM) Year by Year Forecast
Sunshine Biopharma Inc Stock (SBFM) Price Forecast for 2026
The predicted value for Sunshine Biopharma Inc (SBFM) in 2026 is set at an average of $81,903.47. Estimates vary from a peak of $163,806.75 to a trough of $0.1855, indicating an +36.93M% surge from the present price of $0.2218.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $15,155.12 | $2,948.15 | $65,775.67 | +6.83M% |
| December, 2026 | $33,258.39 | $11,006.75 | $163,806.75 | +14.99M% |
Sunshine Biopharma Inc Stock (SBFM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Sunshine Biopharma Inc (SBFM) is $31,572.93, with a high forecast of $62,784.20 and a low forecast of $361.65. This indicates an +14.23M% increase from the last price of $0.2218.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1,761.65 | $361.65 | $62,784.20 | +794.15K% |
| February, 2027 | $7,335.08 | $7,786.71 | $11,241.47 | +3.31M% |
| March, 2027 | $8,106.00 | $8,481.45 | $8,231.81 | +3.65M% |
| April, 2027 | $5,802.73 | $10,380.18 | $8,054.36 | +2.62M% |
| May, 2027 | $8,973.65 | $7,076.91 | $8,173.65 | +4.05M% |
| June, 2027 | $14,620.38 | $10,247.83 | $13,070.38 | +6.59M% |
| July, 2027 | $12,067.12 | $12,767.12 | $12,828.57 | +5.44M% |
| August, 2027 | $12,938.03 | $12,641.30 | $12,595.69 | +5.83M% |
| September, 2027 | $15,032.75 | $13,706.40 | $13,334.77 | +6.78M% |
| October, 2027 | $11,477.50 | $13,909.50 | $13,991.15 | +5.17M% |
| November, 2027 | $7,304.42 | $5,428.23 | $6,079.87 | +3.29M% |
| December, 2027 | $8,409.15 | $8,924.97 | $7,924.97 | +3.79M% |
Sunshine Biopharma Inc Stock (SBFM) Price Forecast for 2028
In 2028, Sunshine Biopharma Inc (SBFM) is projected to reach an average price of $12,898.70, with a high projection of $15,724.06 and a low estimate of $10,073.33. This indicates an +5.82M% rise from the last price of $0.2218.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $12,830.07 | $10,073.33 | $11,770.07 | +5.78M% |
| February, 2028 | $15,108.80 | $12,918.43 | $12,761.34 | +6.81M% |
| March, 2028 | $12,963.54 | $13,563.54 | $12,963.54 | +5.84M% |
| April, 2028 | $14,660.27 | $13,233.72 | $13,760.27 | +6.61M% |
| May, 2028 | $14,285.19 | $14,872.82 | $14,216.45 | +6.44M% |
| June, 2028 | $13,877.92 | $14,413.74 | $13,439.37 | +6.26M% |
| July, 2028 | $14,962.84 | $14,602.10 | $14,698.84 | +6.75M% |
| August, 2028 | $15,997.57 | $16,373.02 | $15,547.20 | +7.21M% |
| September, 2028 | $16,090.30 | $16,329.75 | $15,724.06 | +7.25M% |
| October, 2028 | $15,463.22 | $15,883.68 | $15,640.67 | +6.97M% |
| November, 2028 | $15,329.96 | $15,681.96 | $15,645.77 | +6.91M% |
| December, 2028 | $15,176.69 | $15,534.14 | $15,056.69 | +6.84M% |
Sunshine Biopharma Inc Stock (SBFM) Price Forecast for 2029
The 2029 price forecast for Sunshine Biopharma Inc Stock (SBFM) is $15,960.46 on average, with a high prediction of $18,357.61 and a low estimate of $13,563.31. This represents an +7.20M% increase from the previous price of $0.2218.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $18,577.61 | $15,528.87 | $18,357.61 | +8.38M% |
| February, 2029 | $17,924.34 | $18,196.34 | $18,337.79 | +8.08M% |
| March, 2029 | $17,019.07 | $17,221.07 | $17,710.52 | +7.67M% |
| April, 2029 | $17,813.49 | $17,821.33 | $18,037.62 | +8.03M% |
| May, 2029 | $17,377.14 | $17,392.32 | $17,634.17 | +7.83M% |
| June, 2029 | $16,916.86 | $16,924.46 | $17,275.91 | +7.63M% |
| July, 2029 | $16,309.60 | $16,309.96 | $16,783.68 | +7.35M% |
| August, 2029 | $15,824.71 | $15,826.01 | $16,176.58 | +7.13M% |
| September, 2029 | $15,317.84 | $15,321.64 | $15,697.29 | +6.91M% |
| October, 2029 | $14,690.56 | $14,691.06 | $15,191.83 | +6.62M% |
| November, 2029 | $14,194.04 | $14,194.99 | $14,564.04 | +6.40M% |
| December, 2029 | $13,560.61 | $13,563.31 | $14,061.29 | +6.11M% |
Sunshine Biopharma Inc Stock (SBFM) Price Forecast for 2030
Sunshine Biopharma Inc Stock (SBFM) is expected to reach an average price of $10,229.92 in 2030, with a high forecast of $13,429.99 and a low forecast of $7,029.85. This signifies an +4.61M% surge from the last price of $0.2218.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13,055.84 | $13,056.64 | $13,429.99 | +5.89M% |
| February, 2030 | $12,556.88 | $12,556.88 | $12,929.33 | +5.66M% |
| March, 2030 | $12,054.71 | $12,057.22 | $12,429.76 | +5.43M% |
| April, 2030 | $11,433.83 | $11,434.53 | $11,928.17 | +5.15M% |
| May, 2030 | $10,932.76 | $10,933.21 | $11,307.21 | +4.93M% |
| June, 2030 | $10,428.60 | $10,429.30 | $10,805.95 | +4.70M% |
| July, 2030 | $9,799.31 | $9,800.01 | $10,302.38 | +4.42M% |
| August, 2030 | $9,295.05 | $9,296.45 | $9,673.50 | +4.19M% |
| September, 2030 | $8,666.67 | $8,667.97 | $9,168.77 | +3.91M% |
| October, 2030 | $8,163.32 | $8,164.79 | $8,540.75 | +3.68M% |
| November, 2030 | $7,659.73 | $7,660.13 | $8,037.38 | +3.45M% |
| December, 2030 | $7,028.75 | $7,029.85 | $7,531.62 | +3.17M% |
4.51%
5.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):